<DOC>
	<DOCNO>NCT01589653</DOCNO>
	<brief_summary>This trial conduct Africa Asia . The aim trial compare patient-adjusted versus physician-adjusted titration BIAsp 30 combine metformin type 2 diabetes patient uncontrolled NPH insulin .</brief_summary>
	<brief_title>Comparing Patient-adjusted Versus Physician-adjusted Titration BIAsp 30 Combined With Metformin Type 2 Diabetes Patients</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin aspart , insulin aspart protamine drug combination 30:70</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Biphasic Insulins</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<mesh_term>Insulin , Isophane</mesh_term>
	<criteria>Diagnosed type 2 diabetes minimum 12 month prior screen Currently treat NPH insulin least 3 month prior screen Stable treatment ( change dose regimen ) total daily dose least 1500 mg metformin maximum tolerate dose ( minimum 1000 mg ) ± additional OAD treatment . The metformin treatment must stable least 2 month prior screen HbA1c 7.0 % 10.0 % ( inclusive ) . ( One retest within one week screen visit allow . The last sample conclusive . ) Body Mass Index ( BMI ) equal 40.0 kg/m^2 Able willing eat least 2 main meal day trial Able willing adhere protocol include compliance performance self measure plasma glucose ( SMPG ) , injection regimen titrate accord protocol Experience performing selfmeasured plasma glucose ( SMPG ) Treatment thiazolidinedione ( TZD ) Glucagonlike peptide1 ( GLP1 ) receptor agonist pramlintide within last 3 month prior screen Impaired hepatic function define alanine aminotransferase ( ALAT ) equal 2.5 time upper reference limit . ( One retest within one week screen visit allow . The last sample conclusive . ) Impaired kidney function serum creatinine equal 133 µmol/L ( 1.5 mg/dL ) males equal 124 µmol/L ( 1.4 mg/dL ) female . ( One retest within one week screen visit allow . The last sample conclusive . ) Cardiac problem uncontrolled treated/untreated severe hypertension ( define systolic blood pressure equal 180 mmHg and/or diastolic blood pressure equal 100 mmHg ) Previous use premixed insulin product ( premixed insulin analogue premixed human preparation ) Recurrent severe hypoglycaemia ( 1 severe hypoglycaemic episode , last 12 month ) hypoglycaemic unawareness judge Investigator hospitalisation diabetic ketoacidosis previous 6 month Known proliferative retinopathy maculopathy require treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>